Oxalic Acid

Oxalic Acid

SCHEMBL2420699

O=C(O)C(=O)O.O=C(O)C(=O)O.O=C(O)C(=O)O.O=C(O)CCC(F)(F)F.O=C(O)CCC(F)(F)F.O=C(O)CCC(F)(F)F.[Li+].[Li+].[Li+].[O-]B([O-])[O-]

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 2/20 0.37
MAPK1 P28482 1/20 0.37
SLC13A3 Q8WWT9 1/20 0.37
OR51E2 Q9H255 1/20 0.37
NAALAD2 Q9Y3Q0 1/20 0.35
LMNA P02545 2/20 0.33
ALKBH5 Q6P6C2 1/20 0.33
SUCNR1 Q9BXA5 1/20 0.33
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP1A2 P05177 1/20 0.32
THRB P10828 1/20 0.32
KMT2A Q03164 1/20 0.32
SLC22A6 Q4U2R8 1/20 0.31
OXER1 Q8TDS5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL28801176 0.89 LMNA (0.42) EGLN1MAPK1SLC13A3OR51E2NAALAD2
Tetrylammonium SCHEMBL5022979 0.85 MEN1 (0.34) EGLN1MAPK1SLC13A3OR51E2NAALAD2
Oxalic Acid SCHEMBL5013723 0.84 BBOX1 (0.33) NAALAD2MEN1ALDH1A1CYP1A2THRB
SCHEMBL38157 0.83
SCHEMBL27890788 0.83 LMNA (0.47) EGLN1MAPK1SLC13A3OR51E2NAALAD2
Hydrochloric Acid SCHEMBL6338625 0.81 LMNA (0.44) EGLN1MAPK1SLC13A3OR51E2NAALAD2
Oxalic Acid SCHEMBL175690 0.77 FFAR3 (0.31)
Trifluoroacetic Acid SCHEMBL30548554 0.77 ALDH1A1 (0.41) EGLN1MAPK1SLC13A3OR51E2NAALAD2
SCHEMBL311383 0.74 OR51E2 (0.46) EGLN1MAPK1SLC13A3OR51E2
Succinic Acid SCHEMBL5017078 0.72 LMNA (0.64) EGLN1MAPK1SLC13A3OR51E2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11594758-B2 Secondary battery, electrolytic solution, battery pack, electronic device, and electrical vehicle MURATA MANUFACTURING CO., LTD. (JP) 2023-02-28 US disclosed
US-9912012-B2 Secondary battery, battery pack, electric vehicle, energy storage system, electric power tool, and electronic unit MURATA MANUFACTURING CO., LTD. (JP) 2018-03-06 US disclosed
US-20180048026-A1 SECONDARY BATTERY, ELECTROLYTIC SOLUTION, BATTERY PACK, ELECTRONIC DEVICE, AND ELECTRICAL VEHICLE TOHOKU MURATA MANUFACTURING CO., LTD. (JP) 2018-02-15 US disclosed
US-9806377-B2 Secondary battery, electrolytic solution, battery pack, electronic device, and electrical vehicle SONY CORPORATION (JP) 2017-10-31 US disclosed
US-20170170519-A1 SECONDARY BATTERY, BATTERY PACK, ELECTRIC VEHICLE, ENERGY STORAGE SYSTEM, ELECTRIC POWER TOOL, AND ELECTRONIC UNIT MURATA MANUFACTURING CO., LTD. (JP) 2017-06-15 US disclosed
US-9543613-B2 Secondary battery with electrolytic solution including a methylene cyclic carbonate, battery pack, electric vehicle, energy storage system, electric power tool, and electronic unit including the same SONY CORPORATION (JP) 2017-01-10 US disclosed
CN-102983359-A Secondary battery, battery pack, electric vehicle, energy storage system, electric power tool, and electronic unit SONY CORP 2013-03-20 CN disclosed
US-20130059194-A1 ELECTROLYTIC SOLUTION FOR SECONDARY BATTERY, SECONDARY BATTERY, BATTERY PACK, ELECTRIC VEHICLE, ELECTRIC POWER STORAGE SYSTEM, ELECTRIC POWER TOOL, AND ELECTRONIC DEVICE SONY CORPORATION (JP) 2013-03-07 US disclosed
US-20130059178-A1 SECONDARY BATTERY, BATTERY PACK, ELECTRIC VEHICLE, ENERGY STORAGE SYSTEM, ELECTRIC POWER TOOL, AND ELECTRONIC UNIT SONY CORPORATION (JP) 2013-03-07 US disclosed
US-20130052543-A1 SECONDARY BATTERY, ELECTROLYTIC SOLUTION, BATTERY PACK, ELECTRONIC DEVICE, AND ELECTRICAL VEHICLE SONY CORPORATION (JP) 2013-02-28 US disclosed
EP-2511976-A1 SECONDARY CELL, ELECTROLYTE, CELL PACK, ELECTRONIC DEVICE, ELECTRIC VEHICLE Sony Corporation (JP) 2012-10-17 EP disclosed
US-20110274987-A1 SECONDARY BATTERY, ELECTROLYTIC SOLUTION FOR SECONDARY BATTERY, CYCLIC POLYESTER, ELECTRIC POWER TOOL, ELECTRICAL VEHICLE, AND ELECTRIC POWER STORAGE SYSTEM SONY CORPORATION (JP) 2011-11-10 US disclosed
US-20110229769-A1 LITHIUM SECONDARY BATTERY, ELECTROLYTIC SOLUTION FOR LITHIUM SECONDARY BATTERY, ELECTRIC POWER TOOL, ELECTRICAL VEHICLE, AND ELECTRIC POWER STORAGE SYSTEM SONY CORPORATION (JP) 2011-09-22 US disclosed
US-20110214895-A1 LITHIUM SECONDARY BATTERY, ELECTROLYTIC SOLUTION FOR LITHIUM SECONDARY BATTERY, ELECTRIC POWER TOOL, ELECTRICAL VEHICLE, AND ELECTRIC POWER STORAGE SYSTEM SONY CORPORATION (JP) 2011-09-08 US disclosed
US-20080118845-A1 IONIC COMPOUND, ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, AND BATTERY SONY CORPORATION (JP) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080118845-A1 IONIC COMPOUND, ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, AND BATTERY CA2, DUOX2, OTC EGLN1 4243/4885MAPK1 1392/4885SLC13A3 139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.